Biopharma Events

Where outsourced biomanufacturing performance is defined, benchmarked, and improved.

Where regulatory pioneers, operations leaders, digital quality architects, and manufacturing strategists come together to accelerate biologics manufacturing innovation; from flexible regulatory sandboxes to digital quality frameworks and future workforce strategies.

BioFormulate Live 2026 brings Europe’s formulation, stability, and drug-delivery leaders together in London to shape the next generation of high-performance biologics.

Shaping the future of medicine through cutting-edge RNA therapeutics and manufacturing.

#CGTAsia2026: driving breakthroughs in research, clinical applications, and manufacturing, while addressing Asia’s unique challenges.

Join the Oligonucleotides & Peptides World Asia Congress 2026, where industry leaders from biopharma and big pharma converge to foster collaboration, breakthrough therapies, and scalable manufacturing in Asia’s rapidly growing oligonucleotide and peptide sector.

Biologics Manufacturing Korea 2026 unites global leaders to showcase breakthroughs in AI, automation, biosimilars, and supply chain excellence. Join us to shape the future of biotech in Asia’s powerhouse market.

#ADCBio2026 dives into next-gen ADC development, bridging innovation with clinical and commercial success.

Bringing together top minds from South Korea, Japan, China, and Taiwan, #CGTEA2026 drives breakthroughs in regenerative medicine, gene editing, and personalised therapies—fueling collaboration across biopharma, academia, and CDMOs.

8th Vaccine World Asia Congress 2026 – South East Asia, stands to be an outstanding gathering of leading vaccine experts, researchers, regulators, policymakers, and industry leaders from the SEA region.

Biologics World Southeast Asia 2026 brings together senior decision-makers across biopharma, biotech, and manufacturing to drive innovation, scale-up, and commercialisation of therapeutic biologics across the ASEAN region

Where cross-border leaders come together to define what successful ADC innovation and manufacture looks like in practice: from high-potency logistics to harmonised analytics and next-generation conjugation.

Antibody Engineering Europe 2026 brings together discovery scientists, translational researchers, and platform innovators working to design the next wave of antibody therapeutics. From multispecific formats to AI-enabled discovery and developability optimisation, this is where engineering strategies move from concept to clinical reality.

TIDES Manufacturing Europe 2026 brings together the technical, operational, and supply chain leaders responsible for delivering scalable, compliant production of oligonucleotide and peptide therapeutics.

BioSupply Chain Europe 2026 brings together the operational leaders responsible for ensuring biologics reach patients safely, reliably, and at scale.

The 5th ANZ Biologics Festival 2027 unites biopharma leaders to advance Australia & New Zealand's biologics industry through innovation partnerships and manufacturing expansion.

Biologics World Taiwan 2027 is the leading platform where over 300 global and local experts converge to shape the future of biologics, spanning Manufacturing, R&D, and Clinical Trials for biologic drugs, vaccines and Cell and Gene Therapies.

The region’s premier knowledge-sharing platform, featuring success stories from Asian biopharmas and expert insights from global biomanufacturing leaders on the latest innovations, process optimization, and regulatory advancements.

Join biopharma logistics leaders to explore cold chain innovations and supply chain solutions. Features keynotes, panels, and networking.

Join Clinical Trials Festival Asia 2027, connecting industry leaders to explore innovations in clinical research across Asia.

The 17th Annual Vaccine World Summit unites global stakeholders to advance vaccine development and distribution, emphasizing India's production capacity and developing nations' access.

The 11th Biologics Festival India 2027 is a major life sciences conference focused on advancing vaccine and biologics development for emerging markets.